Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/24/2003US20030077645 Generation of genetically engineered nuclear translocation protein; obtain nucleotide sequences coding receptor protein, insert into expression vector, transform cell, express vector, recover receptor protein
04/24/2003US20030077641 Methods of suppressing microglial activation and systemic inflammatory responses
04/24/2003US20030077640 Generation of vaccine against preferential viral disease; prepare expression vector coding heterologous, transform into plants, express sequences, monitor expression of heterologous protein in plants
04/24/2003US20030077626 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
04/24/2003US20030077624 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer
04/24/2003US20030077623 Nucleotide sequences coding polypeptides for use in gene expression inhibition
04/24/2003US20030077619 Isolating human complimentarity nucleotide sequences; obtain nucleotide sequence, insert into virus, infect plant, propagate plant, detect adjustment in plant phenotype, sequence insert, use for probe in isolating full length
04/24/2003US20030077618 Methods for the early diagnosis of ovarian cancer
04/24/2003US20030077612 Method
04/24/2003US20030077608 Methods, kits and compositions pertaining to combination oligomers and libraries for their preparation
04/24/2003US20030077606 Nucleic acids, proteins, and antibodies
04/24/2003US20030077605 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of dyskinesias
04/24/2003US20030077604 Nucleotide sequences coding polypeptide for use in the treatment , classification and diagnosis of mamary gland cancer
04/24/2003US20030077603 Diagnosing human tumors; obtain body fluid, detect expression of preferential marker, compare to control, evaluate for cancer
04/24/2003US20030077602 Nucleic acids, proteins, and antibodies
04/24/2003US20030077594 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
04/24/2003US20030077593 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders
04/24/2003US20030077591 Nucleic acid for regulating the ABCA7 gene, molecules modulating its activity and therapeutic applications
04/24/2003US20030077590 Nucleotide sequences coding polypeptides for use in te diagnosis and treatment of lymphoma and leukemia
04/24/2003US20030077587 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of vision defects
04/24/2003US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection
04/24/2003US20030077583 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells
04/24/2003US20030077318 Activation lymphocytes; therapy for aids, cancer; immobilization on solid support
04/24/2003US20030077294 Proteinaceous material associated with adenylate cyclase activity in cultures of Bordetella pertussis; useful as components of acellular whooping cough vaccines
04/24/2003US20030077293 Streptococcus antigens
04/24/2003US20030077292 Detection and treatment of cancers of the lung
04/24/2003US20030077290 Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use
04/24/2003US20030077288 Compositions and methods for treatment of muscle wasting
04/24/2003US20030077286 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells
04/24/2003US20030077281 Immunointeractive molecules and uses therefor
04/24/2003US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells
04/24/2003US20030077279 Methods for treating vascular disease by inhibiting toll-like receptor-4
04/24/2003US20030077278 Novel human beta2 integrin alpha subunit
04/24/2003US20030077273 Methods of treating antibody-mediated pathologies using agents which inhibit CD21
04/24/2003US20030077272 Proteinaceous gels having visualization agents and methods of use thereof
04/24/2003US20030077270 Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
04/24/2003US20030077267 Purified forms of DNase
04/24/2003US20030077265 From whole potatoes by ultrafiltration with ammonium bicarbonate
04/24/2003US20030077262 Methods and compositions for modulating apoptosis
04/24/2003US20030077260 Hybrid matrix implants and explants
04/24/2003US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease
04/24/2003US20030077250 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
04/24/2003US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003US20030077226 Cleaving the beta secretase cleavage site of the amyloid precursor protein
04/24/2003CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003CA2476675A1 Neutrokine-alpha and neutrokine-alpha splice variant
04/24/2003CA2466889A1 Use of the adenoviral e2 late promoter
04/24/2003CA2463931A1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes
04/24/2003CA2463925A1 Bone anti-resorptive compounds
04/24/2003CA2463916A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light
04/24/2003CA2463908A1 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
04/24/2003CA2463899A1 Secreted protein, ztnf9
04/24/2003CA2463898A1 Methods and materials for targeting and affecting selected cells
04/24/2003CA2463769A1 Composition and method for treating diabetes
04/24/2003CA2463676A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
04/24/2003CA2463649A1 Rankl mimics and uses thereof
04/24/2003CA2463593A1 Fluorescent protein
04/24/2003CA2463581A1 Microfluidized leishmania antigen and methods of making and using thereof
04/24/2003CA2463578A1 Differentially expressed genes associated with obesity and type 2 diabetes
04/24/2003CA2463492A1 Methods for the treatment of carcinoma
04/24/2003CA2463473A1 Targeted therapeutic proteins
04/24/2003CA2463249A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
04/24/2003CA2463003A1 Dimerized growth factor and materials and methods for producing it
04/24/2003CA2462942A1 Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same
04/24/2003CA2462713A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone
04/24/2003CA2462588A1 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof
04/24/2003CA2461818A1 Treatment and diagnosis of insulin resistant states
04/24/2003CA2461575A1 Use of peptide vectors to improve the immune response to antigens
04/24/2003CA2461542A1 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
04/24/2003CA2461245A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003CA2455899A1 Compositions and methods for the modulation of viral maturation
04/24/2003CA2454578A1 Modified human thymic stromal lymphopoietin
04/23/2003EP1304383A2 Sugarcane bacilliform virus promoter
04/23/2003EP1304382A2 Production of peptides in plants as viral coat protein fusions
04/23/2003EP1304381A2 Process for producing hydrophobic polypeptides, proteins or peptides
04/23/2003EP1304380A1 Human source gene leading sequence, gene vector and gene expression strategy
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304371A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF
04/23/2003EP1304336A2 Antibodies for specific detection of pathogenic prions of human origin and detection methods using them
04/23/2003EP1304335A2 Hepatitis C virus protease
04/23/2003EP1304119A2 Method for preventing and treating hearing loss using a neurturin protein product
04/23/2003EP1304116A1 New class of bioactive glycoprotein
04/23/2003EP1304113A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304112A1 Isolated stromal cells and methods of using the same
04/23/2003EP1303625A2 Alpha-msh related compounds and methods of use
04/23/2003EP1303613A2 Rescue of canine distemper virus from cdna
04/23/2003EP1303612A2 Streptococcus antigens
04/23/2003EP1303611A2 Novel protein containing ring finger domaine r1p4
04/23/2003EP1303610A2 Extracellular matrix protein
04/23/2003EP1303609A2 G-protein coupled receptors
04/23/2003EP1303608A2 Zinc finger domain recognition code and uses thereof
04/23/2003EP1303607A2 High affinity soluble interleukin-18 receptor
04/23/2003EP1303606A2 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
04/23/2003EP1303605A2 Nucleic acids, vectors, host cells, polypeptides, and uses thereof
04/23/2003EP1303604A2 Mammalian receptor proteins; related reagents and methods
04/23/2003EP1303603A2 G protein-coupled receptor con-218
04/23/2003EP1303602A2 Soluble zalpha11 cytokine receptors
04/23/2003EP1303601A2 G protein-coupled receptors
1 ... 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 ... 2916